Skip to content
LinkedIn
Search
Search
The Business of Biofabrication
News
Perspectives
Learn
Landscape
Ricky Solorzano
April 27, 2025
Vivodyne CEO Discusses FDA’s Move Away from Animal Testing and the Future of Humanized Drug Development
Ricky Solorzano
April 27, 2025
Organovo Rebrands as VivoSim Labs to Advance 3D Bioprinting Technology
Ricky Solorzano
April 16, 2025
Cellbricks Reports Preclinical Success with Bioprinted Tissue in Mice
Ricky Solorzano
April 16, 2025
FluidForm Bio Launches $1.24M Crowdfunding Round to Advance Bioprinted Diabetes Therapy
Ricky Solorzano
April 8, 2025
Xylyx Bio Secures $1.125 Million to Advance Innovations in Xenogeneic Cross-Circulation Transplant Organs
Ricky Solorzano
April 3, 2025
Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies
Ricky Solorzano
April 3, 2025
LyGenesis Receives Green Light to Advance Organ Regeneration Trial
Ricky Solorzano
March 18, 2025
How Cellino and Matricelf are Advancing Neural Tissue Engineering
Ricky Solorzano
March 18, 2025
CollPlant Biotechnologies Update – Reports Q3 2024 Results, Advances Regenerative Breast Implant Program
Ricky Solorzano
March 18, 2025
Vericel – Poised for Growth with Expanding Indications and Strong Margins
Ricky Solorzano
Previous Page
1
…
7
8
9
10
11
…
16
Next Page
Archives
Subscribe
Subscribed
The Business of Biofabrication
Sign me up
Have a WordPress.com account?
Log in now.
The Business of Biofabrication
View site in Reader
Manage subscriptions
Sign up
Log in
Report this content
Collapse this bar